Trademark Overview
On Thursday, July 2, 2026, a trademark application was filed for THERINJECT with the United States Patent and Trademark Office. The USPTO has given the THERINJECT trademark a serial number of 99919949. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, July 2, 2026. This trademark is owned by THERINJECT LLC. The THERINJECT trademark is filed in the Pharmaceutical Products category with the following description:
Cells for medical or clinical use; Biological preparations for use in cell cultures for medical purposes; Cell culture media for medical or veterinary purposes; Biologics in the nature of cells for medical use; Pharmaceutical preparations containing cultured cells for use in connection with the diagnosis, treatment, prevention, or management of iron deficiency and iron deficiency anemia; Living cells for veterinary use
